Dosimetric effects of contrast media for catheter-based intravascular brachytherapy

Medical Physics

Volumn 28, Issue 5, 2001, Pages 757-763

  Li, X Allen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Contrast medium; Dose calculation; Intravascular brachytherapy; Monte Carlo

Indexed keywords

CATHETERS; IODINE; MONTE CARLO METHODS; ONCOLOGY; RADIOTHERAPY;

CONTRAST MEDIUM; DOSE CALCULATION; EGSNRC MONTE CARLO; INTRAVASCULAR BRACHYTHERAPY; IODINE CONCENTRATION; IODINE CONTRAST MEDIA; RADIOACTIVE SOURCES; TREATMENT OUTCOMES;

CONTRAST MEDIA;

IODINATED CONTRAST MEDIUM; IRIDIUM 192; STRONTIUM 90;

ARTICLE; BETA RADIATION; BRACHYTHERAPY; CALCULATION; DOSE CALCULATION; DOSIMETRY; GAMMA RADIATION; PRIORITY JOURNAL; RADIATION DOSE; SYSTEM ANALYSIS;

EID: 0342468208     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1367279     Document Type: Article

References (31)

1. D. R. Holmes, Jr. et al., "Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report for the PTCA registry of the National Heart, Lung, and Blood Institute," Am. J. Cardiol. 53, 77C-81C (1984).
2. H. D. Böttcher et al., "Endovascular irradiation - a new method to avoid recurrent stenosis after stent implantation in peripheral arteries: Technique and preliminary results," Int. J. Radiat. Oncol., Biol., Phys. 29, 183-189 (1994).
3. T. A. Fischell et al., "Low-dose, beta particle emission from 'stent' wire results in complete, localized inhibition of smooth muscle cell proliferation," Circulation 90, 2956-2963 (1994).
4. J. Wiederman et al., "Effects of high dose intracoronary irradiation on vasomotor function and smooth muscle histopathology," Am. J. Physiol. 267, H125-H132 (1994).
5. Y. Popowski et al., "High dose rate brachytherapy for prevention of restenosis after percutaneous transluminal coronary angioplasty: Preliminary dosimetric tests of a new source presentation," Int. J. Radiat. Oncol., Biol., Phys. 33, 211-215 (1995).
6. J. A. Condado et al., "Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans," Circulation 96, 727-732 (1997).
7. R. Waksman et al., "Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine: A possible role for radiation therapy in restenosis prevention," Circulation 91, 1533-1539 (1995).
8. Discoveries in Radiation for Restenosis, edited by S. B. King III, R. Waksman, and I. Crocker (Emory University School of Medicine Press, Atlanta, 1995).
9. Handbook of Vascular Brachytherapy, 2nd ed., edited by R. Waksman and P. Serruys (Dunitz, 2000).
10. H. I. Amols et al., "Dosimetric considerations for catheter based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries," Int. J. Radiat. Oncl., Biol., Phys. 36, 913-921 (1996).
11. R. Nath et al., "Intravascular brachytherapy physics: Report of AAPM Radiation Therapy Committee Task Group No. 60," Med. Phys. 26, 119-151 (1999).
12. L. L. Anderson et al. (Interstitial Collaborative Working Group), Interstitial Brachytherapy, Physical, Biological and Clinical Considerations (Raven, New York, 1990).
13. R. Nath et al., "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM radiation therapy committee task group No. 34," Med. Phys. 22, 209-234 (1995).
14. H. I. Amols, F. Trichter, and J. Weinberger, "Intracoronary radiation for prevention of restenosis: Dose perturbations caused by stents," Circulation 98, 2024-2029 (1998).
15. X. A. Li, R. Wang, C. Yu, and M. Suntharalingam, "Beta versus gamma for intravascular brachytherapy: Dosimetric perspectives in the presence of metallic stents and calcified plaques," Int. J. Radiat. Oncol., Biol., Phys. 46, 1043-1049 (2000).
16. S. J. Ye et al., "Dosimetric perturbations of linear array of β emitters and metallic stents in intravascular brachytherapy," Med. Phys. 27, 374-380 (2000).
17. 188Re, Med. Phys. 26, 771-776 (1999).
18. R. S. Mello, H. Callison, J. Winter, A. R. Kagan, and A. Norman, "Radiation dose enhancement in tumors with iodine," Med. Phys. 10, 75-78 (1983).
19. T. D. Solberg, K. S. Iwamoto, and A. Norman, "Calculation of radiation dose enhancement factors for dose enhancement therapy of brain tumors," Phys. Med. Biol. 37, 439-443 (1992).
20. A. V. Mesa, A. Norman, T. D. Solberg, J. J. Demarco, and J. B. Smathers, "Dose distributions using kilovoltage x-rays and dose enhancement from iodine contrast agents," Phys. Med. Biol. 44, 1955-1968 (1999).
21. R. Nath, Y. Ning, and J. Weinberger, "Dose perturbations by high atomic number materials in intravascular brachytherapy," Cardiovasc. Radiat. Med. 1, 144-153 (1999).
22. I. Kawrakow and D. W. O. Rogers, "The EGSnrc code system," NRC Report No. PIRS-701, NRC, Ottawa, 2000.
23. I. Kawrakow, "Accurate condensed history Monte Carlo simulation of electron transport. I. EGSnrc the new EGS4 version," Med. Phys. 27, 485-498 (2000).
24. W. R. Nelson, H. Hirayama, and D. W. O. Rogers, "The EGS4 code system," SLAC-265, Stanford Linear Accelerator Center, Stanford, CA, 1985.
25. A. F. Bielajew and D. W. O. Rogers, "PRESTA: The parameter reduced electron-step transport algorithm for electron Monte Carlo transport," Nucl. Instrum. Methods Phys. Res. B 18, 165-181 (1987).
26. R. Wang, X. A. Li, and C. X. Yu, "Evaluation of EGS4 for Sr-Y 90 intravascular brachytherapy dosimetry," Phys. Med. Biol. 45, 2343-2352 (2000).
27. X. A. Li, R. Wang, C. Yu, L. Weems, and M. Suntharalingam, "Monte Carlo dosimetry for intravascular brachytherapy," XIII. ICCR. 489-491 (2000).
28. R. Wang and X. A. Li, "Monte Carlo calculations of beta-emitting sources for intravascular brachytherapy: A comparison between EGS4, EGSnrc and MCNP," Med. Phys. 28, 134-141 (2001).
29. W. G. Cross, H. Ing, and N. Freedman, "A short atlas of beta-ray spectra," Phys. Med. Biol. 28, 1251-1260 (1983).
30. V. S. Shirley, Nucl. Data Sheets 64, 205 (1991).
31. 192Ir SS sources for intravascular brachytherapy. Med. Phys. 27, 2528-2535 (2000).